These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21873672)

  • 1. Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1).
    Burke TR; Rhee DW; Smith RT; Tsang SH; Allikmets R; Chang S; Lazow MA; Hood DC; Greenstein VC
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8006-15. PubMed ID: 21873672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foveal sparing in Stargardt disease.
    van Huet RA; Bax NM; Westeneng-Van Haaften SC; Muhamad M; Zonneveld-Vrieling MN; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7467-78. PubMed ID: 25324290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy.
    Testa F; Rossi S; Sodi A; Passerini I; Di Iorio V; Della Corte M; Banfi S; Surace EM; Menchini U; Auricchio A; Simonelli F
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4409-15. PubMed ID: 22661472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging.
    Ritter M; Zotter S; Schmidt WM; Bittner RE; Deak GG; Pircher M; Sacu S; Hitzenberger CK; Schmidt-Erfurth UM;
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6416-25. PubMed ID: 23882696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
    Sisk RA; Leng T
    Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption in Bruch membrane in patients with Stargardt disease.
    Park SP; Chang S; Allikmets R; Smith RT; Burke TR; Gregory-Roberts E; Tsang SH
    Ophthalmic Genet; 2012 Mar; 33(1):49-52. PubMed ID: 22060670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full-field ERG as a predictor of the natural course of
    Schroeder M; Kjellström U
    Mol Vis; 2018; 24():1-16. PubMed ID: 29386879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of segmentation density on spectral domain optical coherence tomography assessment in Stargardt disease.
    Velaga SB; Nittala MG; Jenkins D; Melendez J; Ho A; Strauss RW; Scholl HP; Sadda SR
    Graefes Arch Clin Exp Ophthalmol; 2019 Mar; 257(3):549-556. PubMed ID: 30613916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease.
    Chen Y; Ratnam K; Sundquist SM; Lujan B; Ayyagari R; Gudiseva VH; Roorda A; Duncan JL
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3281-92. PubMed ID: 21296825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
    Verdina T; Greenstein VC; Sodi A; Tsang SH; Burke TR; Passerini I; Allikmets R; Virgili G; Cavallini GM; Rizzo S
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absence of fundus abnormalities in Stargardt disease.
    Bax NM; Lambertus S; Cremers FPM; Klevering BJ; Hoyng CB
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1147-1157. PubMed ID: 30903310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
    Schönbach EM; Wolfson Y; Strauss RW; Ibrahim MA; Kong X; Muñoz B; Birch DG; Cideciyan AV; Hahn GA; Nittala M; Sunness JS; Sadda SR; West SK; Scholl HPN;
    JAMA Ophthalmol; 2017 Jul; 135(7):696-703. PubMed ID: 28542693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of peripapillary sparing in non-group I Stargardt disease.
    Burke TR; Allikmets R; Smith RT; Gouras P; Tsang SH
    Exp Eye Res; 2010 Nov; 91(5):592-600. PubMed ID: 20696155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into autofluorescence patterns in Stargardt macular dystrophy using ultra-wide-field imaging.
    Kumar V
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1917-1922. PubMed ID: 28689222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease.
    Gomes NL; Greenstein VC; Carlson JN; Tsang SH; Smith RT; Carr RE; Hood DC; Chang S
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3953-9. PubMed ID: 19324865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic characteristics of late-onset Stargardt's disease.
    Westeneng-van Haaften SC; Boon CJ; Cremers FP; Hoefsloot LH; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Jun; 119(6):1199-210. PubMed ID: 22449572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease.
    Melillo P; Testa F; Rossi S; Di Iorio V; Orrico A; Auricchio A; Simonelli F
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT247-52. PubMed ID: 27409479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripapillary Sparing With Near Infrared Autofluorescence Correlates With Electroretinographic Findings in Patients With Stargardt Disease.
    Nassisi M; Mohand-Saïd S; Andrieu C; Antonio A; Condroyer C; Méjécase C; Dhaenens CM; Sahel JA; Zeitz C; Audo I
    Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):4951-4957. PubMed ID: 31790517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rapid-Onset Chorioretinopathy Phenotype of ABCA4 Disease.
    Tanaka K; Lee W; Zernant J; Schuerch K; Ciccone L; Tsang SH; Sparrow JR; Allikmets R
    Ophthalmology; 2018 Jan; 125(1):89-99. PubMed ID: 28947085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
    Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.